Experience of off-label use of Eltrombopag in the treatment of thrombocytopenia associated with solid tumors by María Henar García Lagunar, Pablo Cerezuela Fuentes, Mónica Martínez Penella, Dolores Paula Gutiérrez-Meca Maestre, María García Coronel, María José Martínez Ortiz

Subjects: “…Eltrombopag…”
Get full text

Feasibility and effectiveness of the prolonged use of eltrombopag in addition to immunosuppression in patients with acquired aplastic anemia: a single-center real-life experience by Monica Carpenedo, Arianna Zappaterra, Lorenzo Del Castello, Beatrice Ferrari, Giulia Cotilli, Davide Paolo Bernasconi, Sara Pezzatti, Filippo Sacco, Lorenza Borin, Andrea Carrer, Luisa Verga, Filippo Brioschi

Subjects: Get full text

PATHOBIOLOGY AND TREATMENT OF HEPATITIS VIRUS-RELATED THROMBOCYTOPENIA by Roberto Stasi, Lian Wea Chia, Pallavi Kalkur, Robert Lown, Muriel S. Shannon

Subjects: “…Viral hepatitis, thrombocytopenia, HCV, thrombopoietin,eltrombopag…”
Get full text

Effects of genetic ablation and pharmacological inhibition of HuR on gene expression, iron metabolism, and hormone levels by Nathalie Idlin, Sivakumar Krishnamoorthy, Magdalena Wolczyk, Mouad Fakhri, Michal Lechowski, Natalia Stec, Jacek Milek, Pratik Kumar Mandal, Jaroslaw Cendrowski, Christos Spanos, Magdalena Dziembowska, Katarzyna Mleczko-Sanecka, Juri Rappsilber, Gracjan Michlewski

Subjects: Get full text

Pharmacoeconomic Analysis of the Use of Thrombopoietin Receptors Agonists in Idiopathic Thrombocytopenic Purpura Therapy by VA Shuvaev, SV Voloshin, AK Hadzhidis, AV Chechetkin

Subjects: Get full text

Results of long-term treatment with thrombopoietin receptor agonists of resistant primary immune thrombocytopenia by O. Yu. Vinogradova, M. M. Pankrashkina, L. A. Mukha, A. L. Neverova, M. V. Chernikov, V. V. Ptushkin

Subjects: Get full text

Development and Validation of Eltrombopag Determination in Human Plasma Blood by HPLC-MS Method by А. М. AL-Dhuraibi, A. L. Kulikov, M. V. Pokrovskiy

Subjects: “…"eltrombopag"…”
Get full text

Thrombopoietin Receptor Agonists in Treatment of Idiopathic Thrompocytopenic Purpura (Primary Immune Thrombocytopenia): Efficacy and Safety in Everyday Clinical Practice by II Zotova, SV Gritsaev, ER Shilova, NA Potikhonova, KМ Abdulkadyrov, AV Chechetkin

Subjects: Get full text

Safety and efficacy of eltrombopag in patients with aplastic anemia: a systematic review and meta-analysis of randomized controlled trials by Huaipeng Guo, Cangchun Liu, Lei Kang, Cong Liu, Ying Liu

Subjects: Get full text

Fisher-Evans syndrome. Casereport in physician’s practice by A. A. Yakushev, I. G. Fedorov, L. Yu. Ilchenko, S. S. Shmycova, N. V. Ilin, G. G. Totolyan, I. O. Sirenova, I. G. Nikitin

Subjects: Get full text

Impact of Thrombopoietin Receptor Agonists on Pathophysiology of Pediatric Immune Thrombocytopenia by Paschalis Evangelidis, Konstantinos Tragiannidis, Eleni Gavriilaki, Athanasios Tragiannidis

Subjects: “…eltrombopag…”
Get full text

Complications of thrombopoietin receptor agonists therapy in patients with immune thrombocytopenia by S. G. Zakharov, T. A. Mitina, A. V. Zakharova, O. P. Madzyara, I. N. Kontievskii, R. V. Vardanyan, E. V. Kataeva, Yu. B. Chernykh, L. L. Vysotskaya, L. V. Ivanitskiy, Yu. Yu. Chuksina, O. R. Zhuravlev, N. V. Gorgun, Z. M. Kharasova, E. V. Trifonova, K. A. Belousov, Z. R. Tekeeva

Subjects: Get full text

Management of patients with immune thrombocytopenia in the Moscow region by S. G. Zakharov, T. A. Mitina, R. V. Vardanyan, I. N. Kontievskiy, A. P. Faenko, Z. R. Tekeeva

Subjects: Get full text

The role of thrombopoietin receptor agonists in the management of adult primary immune thrombocytopenia: A single centre experience by Virijević Marijana, Mitrović Mirjana, Pantić Nikola, Pravdić Zlatko, Sabljić Nikica, Suvajdžić-Vuković Nada

Subjects: “…eltrombopag…”
Get full text

Case Report: Eltrombopag in mosaic and gene therapy-treated patients with Fanconi anemia by Josune Zubicaray, June Iriondo, Elena Sebastián, Alejandro Sanz, Paula Rio, Jean Soulier, Sonsoles San Román, José J. Uriz, Susana Navarro, Eileen Nicoletti, Juan A. Bueren, Jonathan D. Schwartz, Julián Sevilla

Subjects: Get full text

The establishment of an expected concentration reference range for eltrombopag in the individualized treatment of pediatric immune thrombocytopenia by Nan Wang, Nan Wang, Shuyue Dong, Yixin Sun, Yixin Sun, Jingjing Liu, Jingjing Liu, Zhifa Wang, Jingyao Ma, Xiaoling Wang, Runhui Wu, Xiaoling Cheng

Subjects: “…eltrombopag…”
Get full text

A Case of Acute Kidney Injury During Eltrombopag Use Successfully Treated With Plasma Exchange in Addition to Antithrombotic Therapy by Noriko Ueno, Yasuo Kusunoki, Toru Kida, Shun Oda, Akane Yamano, Fumi Nakayama, Shungo Fukuda, Natsuko Ikeda, Tomoko Namba-Hamano, Masato Homma, Masanobu Takeji

Subjects: “…Eltrombopag…”
Get full text

A multicenter mixed-methods study on the effects of intermittent fasting in patients with immune thrombocytopenia receiving thrombopoietin receptor agonists by Mohamed A. Yassin, Mohamed A. Yassin, Muna AlRasheed, Taghreed Al-Eisa, Noura Alhashim, Fiasal Alsayegh, Tarek E. Abouzeid, Mohamed Abd El Fattah, Maryam Alfili, Neveen Shalaby, Neveen Shalaby, Abdullah Alotaibi, Nourah Aljuwaisri, Anwar Almasbahi, Rii Saleeb, Hend Abdelaziz, Awni Alshurafa, Omar Ismail, Rola Ghasoub

Subjects: Get full text

Dose-optimised recombinant human thrombopoietin versus eltrombopag in patients with immune thrombocytopenia: a multicenter, randomised controlled trial (The TE-ITP Study)Research i... by Yunfei Chen, Ting Sun, Da Gao, Wei Wang, Zeping Zhou, Guangxun Gao, Yi Wang, Hu Zhou, Yanping Song, Yinghui Lai, Zhenyu Yan, Jinsong Yan, Jie Bai, Lei Zhang

Subjects: Get full text

Experience of 2^nd line therapy with eltrombopag in patients with immune thrombocytopenia by S. G. Zakharov, T. A. Mitina, R. V. Vardanyan, Z. R. Tekeeva, I. N. Kontievskiy, Yu. Yu. Chuksina, A. V. Zakharova

Subjects: Get full text